Cargando…

Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment

People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnorm...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurpibul, Linda, Namwongprom, Sirianong, Sudjaritruk, Tavitiya, Ounjaijean, Sakaewan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105120/
https://www.ncbi.nlm.nih.gov/pubmed/32226033
http://dx.doi.org/10.1371/journal.pone.0230707
_version_ 1783512346830831616
author Aurpibul, Linda
Namwongprom, Sirianong
Sudjaritruk, Tavitiya
Ounjaijean, Sakaewan
author_facet Aurpibul, Linda
Namwongprom, Sirianong
Sudjaritruk, Tavitiya
Ounjaijean, Sakaewan
author_sort Aurpibul, Linda
collection PubMed
description People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 <25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4–14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m(2)), normal (BMI 18.5–24.9 kg/m(2)), and overweight (BMI ≥ 25.0 kg/m(2)), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0–16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight.
format Online
Article
Text
id pubmed-7105120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71051202020-04-03 Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment Aurpibul, Linda Namwongprom, Sirianong Sudjaritruk, Tavitiya Ounjaijean, Sakaewan PLoS One Research Article People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 <25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4–14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m(2)), normal (BMI 18.5–24.9 kg/m(2)), and overweight (BMI ≥ 25.0 kg/m(2)), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0–16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight. Public Library of Science 2020-03-30 /pmc/articles/PMC7105120/ /pubmed/32226033 http://dx.doi.org/10.1371/journal.pone.0230707 Text en © 2020 Aurpibul et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Aurpibul, Linda
Namwongprom, Sirianong
Sudjaritruk, Tavitiya
Ounjaijean, Sakaewan
Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title_full Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title_fullStr Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title_full_unstemmed Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title_short Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment
title_sort metabolic syndrome, biochemical markers, and body composition in youth living with perinatal hiv infection on antiretroviral treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105120/
https://www.ncbi.nlm.nih.gov/pubmed/32226033
http://dx.doi.org/10.1371/journal.pone.0230707
work_keys_str_mv AT aurpibullinda metabolicsyndromebiochemicalmarkersandbodycompositioninyouthlivingwithperinatalhivinfectiononantiretroviraltreatment
AT namwongpromsirianong metabolicsyndromebiochemicalmarkersandbodycompositioninyouthlivingwithperinatalhivinfectiononantiretroviraltreatment
AT sudjaritruktavitiya metabolicsyndromebiochemicalmarkersandbodycompositioninyouthlivingwithperinatalhivinfectiononantiretroviraltreatment
AT ounjaijeansakaewan metabolicsyndromebiochemicalmarkersandbodycompositioninyouthlivingwithperinatalhivinfectiononantiretroviraltreatment